 SOUTH SAN FRANCISCO, Calif., Sept. 09, 2021 GLOBE NEWSWIRE -- Global Blood Therapeutics, Inc. GBT NASDAQ: GBT today announced that on September 1, 2021, the compensation committee of GBTs board of directors granted 20 new employees options to purchase an aggregate of 49,600 shares of the companys common stock with a per share exercise price of 29.85 and restricted stock units for an aggregate of 79,910 shares of the companys common stock. These awards were made under GBTs Amended and Restated 2017 Inducement Equity Plan the Plan. 